NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/08/2026
Voltar para busca
Dado oficial do USPTO
PERMALINK
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
PERMALINK
ST13
US500000079344648Classe
1, 16, 42
Pedido
79344648
Registro
7272954
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
06/08/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 16, 42
Data de depósito
04/05/2022
Data de registro
16/01/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/01/2024
Última transação
06/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
GIBBONS, BRIAN R
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
IKSUDA THERAPEUTICS LIMITED
Representantes
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.
Classificação técnica
Classes Nice
Classe 1Classe 16Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in industry and science; chemical products for use in industry and sciencevinyl pyridine-based linkers and vinyl pyridine derivatives; reagents for use in scientific apparatus for chemical or biological analysis; reagents for medical research; in-vivo diagnostic reagents for research purposes; chemical preparations for scientific and industrial processes namelyvinyl pyridine-based linkers and vinyl pyridine derivatives; enzymes for scientific purposes; biological cell cultures for use in scientific research
Classe 16
Papercardboard; printed matternamely printed scientific papersposters and books in the fields of biotherapeuticsoncologymedicinescientific literature; printed photographs; stationery; instructional and teaching materialprinted instructional and teaching materials in the fields of biologychemistrybiotherapeuticsoncologymedicine; printed publicationsnamely bookshand-outsworkbooksscientific papers in the fields of biologychemistrybiotherapeuticsoncologymedicine; printed publications for the medical profession namely magazines and newsletters in the fields of biologychemistrybiotherapeuticsoncologymedicine
Classe 42
Industrial analysisanalysis of protein-drug conjugates and biotherapeutics; industrial research servicesindustrial research in the fields of biologychemistrybiotherapeuticsoncologymedicine; biological research; biotechnology testing servicestestinganalysis and evaluation of biotherapeutics for medical and scientific research purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific researchconducting clinical trials for others; medical and scientific researchdesigning clinical trials for others in the fields of vaccines and gene therapy; scientific research for medical purposes; scientific research for medical purposes in the area of cancerous diseases
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
29/11/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/05/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
17/04/2024
FIMP
FINAL DISPOSITION PROCESSED
17/04/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
16/04/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
16/01/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
16/01/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/01/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/12/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
20/12/2023
GPNX
NOTIFICATION PROCESSED BY IB
31/10/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/10/2023
PUBO
PUBLISHED FOR OPPOSITION
31/10/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/10/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/10/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/09/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/08/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/08/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/08/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/08/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/08/2023
RFNT
REFUSAL PROCESSED BY IB
17/05/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
24/04/2023
RFRR
REFUSAL PROCESSED BY MPU
24/04/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/03/2023
CNRT
NON-FINAL ACTION WRITTEN
01/03/2023
DOCK
ASSIGNED TO EXAMINER
23/02/2023
MAFR
APPLICATION FILING RECEIPT MAILED
19/07/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/07/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
14/07/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PERMALINK ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.